Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1989
T cell receptor beta-chain selection in human allograft rejectionM C Miceli, O J FinnHuman Immunology|July 1, 1988
Human allograft-derived T-cell lines: donor class I- and class II-directed cytotoxicity and repertoire stability in sequential biopsiesM C Miceli, T S Barry, O J FinnHuman Immunology|November 1, 1988
Human suppressor T cells induced in vitro with an autologous renal allograft-derived T cell line. I. Suppressor cell induction, function, and specificityM Emara, M C Miceli, O J Finn, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2012
Immuno-oncology: understanding the function and dysfunction of the immune system in cancerO J FinnBiotherapy (Dordrecht, Netherlands)|January 1, 1992
Antigen-specific, MHC-unrestricted T cellsO J FinnCurrent Opinion in Immunology|October 1, 1993
Tumor-rejection antigens recognized by T lymphocytesO J FinnBiomedical Peptides, Proteins & Nucleic Acids : Structure, Synthesis & Biological Activity|January 1, 1995
Recombinant epithelial cell mucin (MUC-1) expressed in baculovirus resembles antigenically tumor associated mucin, target for cancer immunotherapyP Ciborowski, O J FinnProceedings of the National Academy of Sciences of the United States of America|February 20, 1996
Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cellsG Pecher, O J FinnCell Death and Differentiation|November 17, 2007
T-cell death and cancer immune toleranceB Lu, O J FinnCancer Research|June 19, 2001
Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patientsJ Schmielau, O J FinnPageof 10